C. Lander

Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.

O. Cummings, E. Mickler, G. Sandusky, 2013, American journal of respiratory cell and molecular biology.

Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction

M. Willis, B. Cooley, C. Lander, 2016, International Journal of Peptide Research and Therapeutics.

MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.

C. Patterson, Liang Xie, M. Willis, 2014, Journal of molecular and cellular cardiology.

An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticles

Brian C Evans, C. Duvall, C. Gersbach, 2019, Nature Communications.

Nicotinic cholinergic modulation: galantamine as a prototype.

H. Geerts, D. Woodruff-Pak, C. Lander, 2006, CNS drug reviews.

MMI‐0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein C

M. Willis, J. Robbins, J. Gulick, 2017, Journal of the American Heart Association.